Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04356261 · ClinicalTrials.gov registry record · NA

Revolutionizing Normative Re-education

A NA study, sponsored by Loyola Marymount University.

Completed
Registry status
NA
Development phase
1,143
Enrollment target

NCT04356261 is a NA study that has completed, run by Loyola Marymount University. The registered enrollment target is 1,143 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04356261, a NA study, has completed, sponsored by Loyola Marymount University.

COMPLETED
Registry status
NA
Development phase
1,143 participants
Enrollment target

Study Summary

Personalized Normative Feedback (PNF), the most widely-used college alcohol intervention approach, suffers from several limitations innovatively remedied in the current proposal through CampusGANDR, a smartphone-based app for college students that delivers alcohol-related PNF within a weekly game centered around testing first-year students' perceptions about the attitudes and behaviors of their peers in a variety of campus-relevant domains. Five pilot studies suggest that CampusGANDR will be significantly more effective at correcting students' normative misperceptions and reducing their alcohol use than standard PNF, especially among heavier-drinking students and those with greater exposure to alcohol on social media, and that these larger effects are driven by the significantly decreased psychological reactance experienced by students when viewing feedback as part of a game about college life rather than as part of an alcohol-focused program. The current project seeks to 1) evaluate the efficacy of CampusGANDR in a large-scale multi-site trial, 2) identify the optimal dosage of alcohol feedback to deliver within CampusGANDR for correcting norms and reducing alcohol use across 12 weeks of gameplay among non-drinking, moderate-drinking, and heavy-drinking students, 3) examine person-level moderators of these effects, and 4) evaluate CampusGANDR engagement and sustainability among students who play voluntarily but are not involved in the randomized controlled trial.

Interventions

  • BEHAVIORAL Gamified Personalized Normative Feedback

Trial Details

FieldValue
Enrollment Target 1,143 participants
Start Date 2021-08-15
Est. Completion 2024-10-25
Phase NA

Sponsor

Loyola Marymount University

7 total trials

What the Registry Record Tells You About NCT04356261

The ClinicalTrials.gov registry entry for NCT04356261 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola Marymount University, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Gamified Personalized Normative Feedback is the first listed.

NCT04356261 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04356261 about?

NCT04356261 is a clinical study titled "Revolutionizing Normative Re-education". Personalized Normative Feedback (PNF), the most widely-used college alcohol intervention approach, suffers from several limitations innovatively remedied in the current proposal through CampusGANDR, a smartphone-based app for college students that delivers alcohol-related PNF within a weekly game ce...

What is the current status of trial NCT04356261?

This trial is currently completed. It is a NA study. The enrollment target is 1,143 participants. The study started on 2021-08-15. Estimated completion is 2024-10-25.

What interventions are being tested in trial NCT04356261?

The interventions under investigation include: Gamified Personalized Normative Feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT04356261?

This trial is sponsored by Loyola Marymount University, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.